Literature DB >> 11688186

[Multiple sclerosis. Chlamydia hypothesis in debate].

T Derfuss1, R Hohlfeld, E Meinl.   

Abstract

Recently, an association between multiple sclerosis and Chlamydia pneumoniae infection has been suggested. Because standardized PCR protocols are lacking, a series of studies could not clarify whether C. pneumoniae is present in brain tissue and CSF of MS patients. Therefore, other studies focused on the humoral immune response against C. pneumoniae: 24% of MS patients, but only 5% of the control patients showed intrathecally produced antibodies against C. pneumoniae. If an infection with C. pneumoniae was involved in the pathogenesis of MS, one would expect that, in analogy to other infections of the CNS, the oligoclonal bands in the CSF of MS patients would recognize the responsible agent. However, the results we obtained by affinity-mediated immunoblots showed that the oligoclonal bands in the CSF of MS patients are not directed against Chlamydia antigen. In contrast to this, we found that the immunoglobulins in the CSF of neuroborreliosis patients reacted strongly against Borrelia antigen in the affinity-mediated immunoblots. In light of these results we assume that the intrathecal immunoglobulin production against C. pneumoniae is part of a polyspecific immune response. Thus, it is not likely that C. pneumoniae is causally linked to the pathogenesis of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11688186     DOI: 10.1007/s001150170041

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  3 in total

1.  The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.

Authors:  Tilman Hottenrott; Elisabeth Schorb; Kristina Fritsch; Rick Dersch; Benjamin Berger; Daniela Huzly; Sebastian Rauer; Ludger Tebartz van Elst; Dominique Endres; Oliver Stich
Journal:  J Neurol       Date:  2018-03-06       Impact factor: 4.849

Review 2.  [Rituximab in treatment for neuroimmunological diseases].

Authors:  A Schröder; G Ellrichmann; G Chehab; M Schneider; R A Linker; R Gold
Journal:  Nervenarzt       Date:  2009-02       Impact factor: 1.214

3.  Detection of Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis by combination of cell culture and PCR: no evidence for possible association.

Authors:  Stylianos Chatzipanagiotou; Constantinos Tsakanikas; Maria Anagnostouli; Michalis Rentzos; Anastassios Ioannidis; Chryssoula Nicolaou
Journal:  Mol Diagn       Date:  2003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.